[Hypera Pharma SA] is shoring up its position as the dominant player in Brazil’s consumer healthcare market by striking a deal to acquire a portfolio of OTC and Rx drugs from Japan’s Takeda Pharmaceutical Co. Ltd. for $825m. The transaction is expected to close by the end of 2020.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?